![]() Deciphera Pharmaceuticals Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines for patients with cancer. | ||
Founding Date | Founding Date 2000 | Founding Date 2003 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Tübingen, DE HQ Ottignies Louvain La Neuve, BE Wiesbaden, DE Amsterdam, NL Basel, CH Boston, US | Locations Waltham, US HQ Lawrence, US |
Employees | Employees 82517% decrease | Employees 35037% increase |
Valuation ($) | Valuation ($) 648.3 m | Valuation ($) 2.2 b |
Financial | ||
Revenue (est.) | Revenue (est.) €535.2m (FY, 2024) | Revenue (est.) $163.4m (FY, 2023) |
Cost of goods | Cost of goods €9.7m (FY, 2024) | Cost of goods $3.7m (FY, 2023) |
Gross profit | Gross profit €534.4m (FY, 2024) | Gross profit $159.6m (FY, 2023) |
Net income | Net income €162.2m (FY, 2024) | Net income ($194.9m) (FY, 2023) |
Operating ⚠ | ||
Patent Applications | Patent Applications 500 (Mar, 2020) | Patent Applications 49 (Aug, 2017) |
Funding | ||
Total funding raised | Total funding raised $ 1.1b | Total funding raised $ 714m |

Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines for patients with cancer.
View company